For example, TERT promoter (pTERT) mutations were rarely found in the TCGA analysis; from 291 GBM patients with WES data 42 had whole genome NGS but only 25 samples had adequate coverage (read count > 10) of the TERT promoter for mutational analysis [12]. The gene discussed is TERT; the disease is glioblastoma.